Michael Tsoukas

Assistant Professor of Medicine

McGill University Health Centre

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Tsoukas is an Assistant Professor of Medicine at McGill University Health Centre, Canada. His research primarily focuses on the intersection of cardiovascular health and diabetes, with recent articles exploring topics such as the effects of naltrexone/bupropion on body composition and the impact of age of obesity onset on adipose tissue. His work also includes investigations into novel treatment approaches for type 1 diabetes and the importance of synchronous care for improving health outcomes in patients with type 2 diabetes.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Amir Razaghizad

McGill University

CANADA

View details

Clare Arnott

AUSTRALIA

View details

Tamar Tchkonia

Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

Jochen Seufert

GERMANY

View details

José Morais

Professor

McGill University

CANADA

View details

Brendon Neuen

The George Institute for Global Health

AUSTRALIA

View details

Alessandra Kobayati

McGill University

CANADA

View details

Sylvia Santosa

Associate Professor

Concordia University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Tsoukas

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Characterization of the effect of naltrexone/bupropion on body composition

Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the CANVAS Program and CREDENCE trial

Age of obesity onset affects subcutaneous adipose tissue cellularity differently in the abdominal and femoral region

Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof‐of‐concept results from the DECIDE‐CV clinical programme

Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE

Senescence markers in subcutaneous preadipocytes differ in childhood‐ versus adult‐onset obesity before and after weight loss

Glucagon‐like peptide‐1 receptor agonists as adjunctive treatment for type 1 diabetes: Renewed opportunities through tailored approaches?

Sex Affects Regional Variations in Subcutaneous Adipose Tissue T Cells but not Macrophages in Adults with Obesity

A novel dual-hormone insulin- and-pramlintide artificial pancreas for type 1 diabetes: A randomized controlled crossover trial

Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age

Collaborators (8)

Amir Razaghizad

Clare Arnott

Tamar Tchkonia

Jochen Seufert

José Morais

Brendon Neuen

Alessandra Kobayati

Sylvia Santosa

Make your next move.